Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ÿ¾×¼± »óÇǼº Á¾¾çÀÇ ÀÓ»óÀû ¹× º´¸®Á¶Á÷ÇÐÀû °íÂû Clinical and Histopathological Studies on Salivary Gland epithelial Tumors

´ëÇѺ´¸®ÇÐȸÁö 1986³â 20±Ç 1È£ p.26 ~ 34
Ȳ¼ø¿­, ¼­°­¼®,
¼Ò¼Ó »ó¼¼Á¤º¸
Ȳ¼ø¿­ (  ) 
ºÎ»ê´ëÇб³

¼­°­¼® (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract

¿ä ¾à
ÀúÀÚ´Â 1973³â 1¿ùºÎÅÍ 1984³â 7¿ù±îÁö ¸¸ 11³â 7°³¿ù°£ ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ¼Óº´¿ø
Çغκ´¸®°ú¿¡¼­ È®ÁøµÈ 111¿¹ÀÇ Å¸¾×¼± »óÇǼº Á¾¾çÀ» °ËÅäÇÏ°í, ´ÙÀ½°ú °°ÀÌ ¿ä¾àÇÑ´Ù.
1) ÃÑ 111¿¹ÀÇ Å¸¾×¼± »óÇǼº Á¾¾çÁß ¾ç¼ºÁ¾¾çÀÌ 72¿¹(64.9%), ¾Ç¼ºÁ¾¾çÀÌ 39¿¹(35. 1%)¿´
°í, ³²¿© ºñÀ²Àº 1 : 1.6À¸·Î¼­ ¿©ÀÚ¿¡¼­ ºó¹ßÇÏ¿´´Ù. ¾ç¼ºÁ¾¾çÀÇ Æò±Õ¿¬·ÉÀº 39.6¼¼, ¾Ç¼ºÁ¾
¾çÀÇ Æò±Õ¿¬·ÉÀº 44.6¼¼¿´´Ù.
2) Ÿ¾×¼± »óÇǼº Á¾¾çÀÇ Á¶Á÷ÇÐÀû À¯ÇüÀÇ ºóµµ´Â ´ÙÇü¼º ¼±Á¾ÀÌ 63¿¹(56.8%)·Î °¡Àå ¸¹
¾Ò°í, ±× ´ÙÀ½À¸·Î Á¡¾×»óÇǾç¾ÏÀÌ 14¿¹(12.6%), ¼±¾ç³¶Á¾¾ÏÀÌ 11¿¹(9.9%), ¼±ÀÓÆÄÁ¾°ú ¼±¾Ï
ÀÌ °¢°¢ 4¿¹(3.6%)µîÀÇ ¼øÀ§¿´´Ù.
3) Ÿ¾×¼± »óÇǼº Á¾¾çÀº ´ëŸ¾×¼±¿¡¼­ 62¿¹(56.9%), ¼ÒŸ¾×¼±¿¡¼­ 47¿¹(43.1%) ¹ß»ýÇÏ¿´
´Âµ¥, È£¹ßºÎÀ§´Â ÀÌÇϼ±¾Æ 38¿¹(34.9%)·Î¼­ °¡Àå ¸¹¾Ò°í, ±× ´ÙÀ½À¸·Î í­(ÀÚ)ij°¡29¿¹
(26.6%), ¾ÇÇϼ±ÀÌ 20¿¹(18.3%)µîÀÇ ¼øÀ§¿´´Ù.
4) Á¾¾çÀÇ Æò±Õ Å©±â´Â ¾ç¼ºÁ¾¾çÀÇ Á÷°æÀº 3.5cm, ¾Ç¼ºÁ¾¾çÀÇ Á÷°æÀº 3.6cm·Î¼­, ±× Å©±â
¿¡ Â÷ÀÌ°¡ ¾ø¾ú°í, Æò±Õ º´·Â±â°£Àº ¾ç¼ºÁ¾¾çÀÌ 5³â 3°³¿ù, ¾Ç¼ºÁ¾¾çÀÌ 2³â 4°³¿ù·Î¼­, ¾Ç¼º
Á¾¾ç¿¡¼­ º´·Â±â°£ÀÌ ÈξÀ ª¾Ò´Ù.
5) ȯÀÚÀÇ ÀÓ»óÁõ»óÀº Á¾±«ÃËÁö°¡ ¾ç¼ºÁ¾¾ç¿¡¼­ 97.2%, ¾Ç¼ºÁ¾¾ç¿¡¼­ 89.7%·Î¼­ ´ëºÎºÐÀ»
Â÷ÁöÇÏ¿´°í, ±× ´ÙÀ½À¸·Î ¾Ç¼ºÁ¾¾çÀº µ¿ÅëÀÌ 23.1%, ±«¾ç°ú ÃâÇ÷ÀÌ °¢°¢ 15.4%µîÀÇ ¼øÀ§¿´
°í, ¾ç¼ºÁ¾¾çÀº ¾È±¸µ¹ÃâÀÌ 5.6%, ±«¾çÀÌ 4.2%µîÀÌ ¼øÀ§¿´´Ù.
6) ´ÙÇü¼º¼±Á¾ 67¿¹Áß ¾Ç¼ºÇüÀÌ 4¿¹ (6.0%)¿´´Ù.
#ÃÊ·Ï#
The author has studied the 111 masses of salivary gland epithelial tumors which
confirmed clinically and pathologically during the period of 11 years and 7 months from
1973 to 1984 at Pusan National University Hospital.
The results of the studs were summarized as follows :
1) Among 111 cases of salivary gland epithelial tumors, benign tumors were 72
cases(64.9%) and malignant tumors 39 cases(35. 1%). The male to female ratio of
overall salivary gland epithelial tumors was 1 to 1.6. Mean age of benign tumors was
3g.6 years old and that of malignant tumors 44.6.
2) The analysis of the salivary gland epithelial tumors in histologic type revealed 63
cases (56.8%) of pleomorphic adenoma, 14 cases(12.6%.) of the mucoepidermoid
carcinoma, 11 cased(9.9%) of adenoid cystic carcinoma, 4 cases(3.6%) of
adenoly-mphoma and adenocarcinoma, respectively.
3) The incidence of salivary gland epithelial tumors was found to be in the major
salivary gland in 62 cases(56.9%), in the minor salivary gland in 47 cases(43.1%),
preferably involving parotid gland in 38 cases(34.9%), palate in 29 cases(26.6%),
submandibular gland in 20 cases (18.3%) in order of frequency.
4) The mean size of benign salivary gland epithelial tumors was 3.5 cm in diameter
and that of malignant 3.6 cm. Therefore, the size of both benign and malignant tumors
was not significantly different. The mean duration of chief complaints of salivary gland
epithelial tumors was 5 years and 3 months in benign type, 2 years and 4 months in
malignant type, approximately half of the benign tumors.
5) The most frequent manifestation in malignant tumors was palpable mass
89.7%(benign : 97.2%), pain 23.1%, ulcer and hemorrhage 15.4%, respectively, et at.,
whereas, that of benign tumors was exophthalmos 5.6%, ulcer 4.2%, et al. in order of
frequency. 6) Among the 67 cases of pleomorphic adenoma, 4 cases(6.0%) of them were
malignant type.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS